George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

16 Jan 2023 07:00

RNS Number : 7481M
Quixant PLC
16 January 2023
 

16 January 2023

Quixant plc

("Quixant" or the "Group")

Trading Update and Notice of Results

Record annual revenues

 

Quixant (AIM:QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, provides an update on trading for the financial year ended 31 December 2022 ("FY22").

 

Trading

 

The Board is pleased to confirm that, further to upgrading FY22 revenue expectations on 13 October 2022, positive trading across both the Gaming and Densitron businesses continued through the fourth quarter, reflecting the strong demand for our products. The Board expects to report full year revenues of $119.9m, 38% up year-on-year, the highest revenue performance in the Group's history, and slightly ahead of market expectations1. This is despite the backdrop of substantial supply and economic disruption. The Gaming business posted revenues of $74.1m, representing its best performance since 2018 and the Densitron business delivered $45.8m, beating the revenue record set in FY21 by 15%. 

 

The Group expects adjusted profit before tax to be slightly ahead of market expectations1. Whilst supply chain challenges persisted through the second half of FY22, a stabilisation in component pricing led to a partial recovery in gross margins towards historic levels.

 

FY22

FY21

Change

($m)

($m)

 

Group Revenue

119.9

87.1

38%

Gaming Revenue

74.1

 

47.3

 

57%

Densitron Revenue

45.8

 

39.8

 

15%

 

 

 

 

 

 

Financial position

 

Net cash at 31 December 2022 increased to $12.9m from $12.0m at 30 June 2022, driven by lower working capital requirements as the Group reduced the level of its strategic inventory holdings.

 

Outlook

 

The Group starts the new financial year with a strong order book, which provides good forward visibility supporting further revenue growth in FY23. Management continues to monitor macro-economic challenges, including recession, ongoing supply risks and inflationary pressures, but believes that the Group is well placed to continue to deliver good growth given its resilient end-markets and strategic positioning.

 

Notice of Results

The Group expects to report its full year results for 2022 on 21 March 2023.

Jon Jayal, Chief Executive Officer of Quixant plc, commented: "The Group has delivered an excellent year of growth, significantly ahead of initial expectations. Against a backdrop characterised by substantial supply and economic disruption, this performance is even more pleasing.

 

"This is testament to the strength of our customer relationships, quality of our people, resiliency in our management of supply chains and the value attributed to our innovative technology solutions. Driven by our growth strategy, we have exited the year with a more diversified product set, broader customer base and more robust platform from which to grow.

 

"As we start the new year, we remain cognisant of wider recessionary challenges however a robust order book supports further growth in FY23. We believe our business strategy positions us well for long-term diversified growth in the Group's revenue and profits."

 

1 The current range of forecasts for the year ended 31 December 2022 is revenue of between $115.3m and $115.1m with a consensus of $115.2m and adjusted profit before tax of $10.1m.

 

 

Quixant plc

Jon Jayal, Chief Executive Officer

Johan Olivier, Chief Financial Officer

 

Tel: +44 (0)1223 892 696

Nominated Adviser and Broker:

finnCap Ltd

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane / Charlotte Sutcliffe (ECM)

 

Tel: +44 (0) 20 7220 0500

Joint Broker:

Canaccord Genuity Limited

Simon Bridges / Andrew Potts

 

Tel: +44 (0) 20 7523 8000

Financial PR:

Alma PR

Hilary Buchanan / Kieran Breheny / Will Ellis Hancock

Tel: +44 (0)20 3405 0205

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK, with offices throughout Europe, North America and Asia. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support teams based in Italy and Slovenia. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMMZKNGFZM
Date   Source Headline
27th Apr 20234:53 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement and Proposed Name Change
14th Apr 20237:00 amRNSExercise of options
4th Apr 20237:00 amRNSReport and Accounts and Notice of AGM
3rd Apr 20235:52 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of Options
21st Mar 20237:00 amRNSFinal Results
21st Feb 20237:00 amRNSNotice of Results and Investor Presentation
17th Jan 20238:15 amRNSExercise of options
16th Jan 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20238:59 amRNSHolding(s) in Company
3rd Nov 202212:09 pmRNSDirector Shareholding
26th Oct 20228:20 amRNSDirector Shareholding
14th Oct 20227:23 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
13th Sep 20227:00 amRNSAppointment of Non-Executive Directors
6th Sep 20227:00 amRNSInterim Results
1st Sep 20227:00 amRNSMass production order for gaming cabinet solutions
31st Aug 20227:00 amRNSNotice of Results and Presentations
14th Jul 20227:00 amRNSTrading Update and Notice of Results
9th May 20226:04 pmRNSGrant of Options
5th May 202211:55 amRNSResult of AGM
5th May 20227:00 amRNSAGM Statement
11th Apr 202211:37 amRNSReport and Accounts and Notice of AGM
5th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSNotice of Results and Presentations
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update and Notice of Results
29th Oct 20212:28 pmRNSGrant of Options
22nd Sep 20217:00 amRNSInterim Results
15th Sep 20217:00 amRNSInvestor Presentation
5th Aug 202111:16 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSTrading Update and Notice of Results
12th Jul 20213:02 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSAppointment of CFO
1st Jul 20217:00 amRNSDirector Shareholding
6th May 20215:12 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
19th Apr 20216:07 pmRNSHolding(s) in Company
19th Apr 20215:48 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSFinal Results
9th Apr 20214:40 pmRNSRescheduled Investor Presentation
9th Apr 20213:41 pmRNSAnnouncement of Final Results
6th Apr 20217:00 amRNSInvestor Presentation
26th Feb 20217:00 amRNSNotice of Results
12th Feb 20217:00 amRNSAppointment of Joint Broker
27th Jan 20217:00 amRNSTrading Update and Notice of Results
15th Jan 20217:00 amRNSAppointment of New Senior Independent NED
10th Dec 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.